Eight pathways included immune and inflammatory processes (amoebiasis, prostate cancer, rheumatoid arthritis, relaxin, viral protein interaction with cytokine and cytokine receptor, MARK signalling, AMPK signalling, and PI3K-Akt signalling). The gene discussed is MARK1; the disease is Familial prostate cancer.